UKONS 2018 | CAR T-cell therapy: co-operation could lead to unprecedented levels of efficacy

David Irvine

David Irvine, MBChB, PhD, from the University of Glasgow, Glasgow, UK, speaks at the Oncology Nursing Society (UKONS) 2018 Annual Conference, held in Glasgow, UK, about the challenges associated with the implementation of chimeric antigen receptor (CAR) T-cell therapy. Dr Irvine reveals the procedures required by healthcare professionals to overcome these challenges, before offering an insight into the exciting prospect of this revolutionary new therapy.

Share this video